CN106420643A - 一种含维生素c钠的咀嚼片及其制备方法 - Google Patents
一种含维生素c钠的咀嚼片及其制备方法 Download PDFInfo
- Publication number
- CN106420643A CN106420643A CN201610964478.5A CN201610964478A CN106420643A CN 106420643 A CN106420643 A CN 106420643A CN 201610964478 A CN201610964478 A CN 201610964478A CN 106420643 A CN106420643 A CN 106420643A
- Authority
- CN
- China
- Prior art keywords
- sodium
- parts
- vitamine
- chewable tablets
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011734 sodium Substances 0.000 title claims abstract description 56
- 229910052708 sodium Inorganic materials 0.000 title claims abstract description 56
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title claims abstract description 41
- 239000007910 chewable tablet Substances 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title abstract description 33
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 title abstract description 17
- 229930003268 Vitamin C Natural products 0.000 title abstract description 17
- 235000019154 vitamin C Nutrition 0.000 title abstract description 17
- 239000011718 vitamin C Substances 0.000 title abstract description 17
- 229940068682 chewable tablet Drugs 0.000 title abstract description 7
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 30
- 229920002472 Starch Polymers 0.000 claims abstract description 25
- 239000008107 starch Substances 0.000 claims abstract description 25
- 235000019698 starch Nutrition 0.000 claims abstract description 25
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims abstract description 17
- 229930195725 Mannitol Natural products 0.000 claims abstract description 17
- 239000000594 mannitol Substances 0.000 claims abstract description 17
- 235000010355 mannitol Nutrition 0.000 claims abstract description 17
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 15
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 14
- 239000003765 sweetening agent Substances 0.000 claims abstract description 14
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 13
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 13
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 13
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 9
- 239000011782 vitamin Substances 0.000 claims description 35
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 claims description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 32
- 239000003826 tablet Substances 0.000 claims description 24
- 239000002245 particle Substances 0.000 claims description 20
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 claims description 12
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 10
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 10
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 10
- 239000011812 mixed powder Substances 0.000 claims description 10
- 239000004384 Neotame Substances 0.000 claims description 6
- 229930189775 mogroside Natural products 0.000 claims description 6
- 235000019412 neotame Nutrition 0.000 claims description 6
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 claims description 6
- 108010070257 neotame Proteins 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 5
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 5
- 235000015424 sodium Nutrition 0.000 claims description 5
- 239000011122 softwood Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 235000020985 whole grains Nutrition 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims 2
- 229910052938 sodium sulfate Inorganic materials 0.000 claims 1
- 235000011152 sodium sulphate Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 235000009508 confectionery Nutrition 0.000 abstract description 7
- 210000000214 mouth Anatomy 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 3
- 210000001156 gastric mucosa Anatomy 0.000 abstract description 2
- 238000003860 storage Methods 0.000 abstract description 2
- 244000246386 Mentha pulegium Species 0.000 abstract 1
- 235000016257 Mentha pulegium Nutrition 0.000 abstract 1
- 235000004357 Mentha x piperita Nutrition 0.000 abstract 1
- 229920003081 Povidone K 30 Polymers 0.000 abstract 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 abstract 1
- 235000001050 hortel pimenta Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 230000007774 longterm Effects 0.000 description 8
- 108010011485 Aspartame Proteins 0.000 description 7
- 239000000605 aspartame Substances 0.000 description 7
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical group OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 7
- 235000010357 aspartame Nutrition 0.000 description 7
- 229960003438 aspartame Drugs 0.000 description 7
- 239000000080 wetting agent Substances 0.000 description 7
- 238000005469 granulation Methods 0.000 description 6
- 230000003179 granulation Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000035473 Communicable disease Diseases 0.000 description 4
- -1 Sodium dialkyl sulfate Chemical class 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 239000000314 lubricant Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- 210000003238 esophagus Anatomy 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000008935 nutritious Nutrition 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 238000013112 stability test Methods 0.000 description 3
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 208000010428 Muscle Weakness Diseases 0.000 description 2
- 206010028372 Muscular weakness Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 206010037549 Purpura Diseases 0.000 description 2
- 241001672981 Purpura Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 206010047623 Vitamin C deficiency Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008085 renal dysfunction Effects 0.000 description 2
- 208000010233 scurvy Diseases 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000005550 wet granulation Methods 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- KPQJOKRSYYJJEL-VLQRKCJKSA-K [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O Chemical compound [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O KPQJOKRSYYJJEL-VLQRKCJKSA-K 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 229960004016 sucrose syrup Drugs 0.000 description 1
- 210000000515 tooth Anatomy 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G3/368—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/31—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives
- A23L27/32—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives containing dipeptides or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/035—Organic compounds containing oxygen as heteroatom
- A23L29/04—Fatty acids or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/055—Organic compounds containing sulfur as heteroatom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
- A23L29/219—Chemically modified starch; Reaction or complexation products of starch with other chemicals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/262—Cellulose; Derivatives thereof, e.g. ethers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/37—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Dispersion Chemistry (AREA)
- Mycology (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Inorganic Chemistry (AREA)
- Cardiology (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
Abstract
本发明公开了一种含维生素C钠的咀嚼片,该咀嚼片包括以下重量份的组分:维生素C钠20‑100份、淀粉100‑500份、甜味剂10‑30份、甘露醇5‑20份、微晶纤维素30‑100份、聚维酮K‑30 5‑20份、羧甲基淀粉钠20‑60份、十二烷基硫酸钠5‑20份、硬脂酸镁1‑5份、薄荷香精0.1‑0.5份。本发明针对现有维生素C咀嚼片溶解后酸性大、对口腔、咽喉食道以及胃粘膜刺激较大、不宜长期服用,及存储过程中维生素C容易氧化失效、咀嚼片易受潮吸湿等问题,提供一种含维生素C钠的咀嚼片,制剂简便,口感香甜,质量稳定。
Description
技术领域
本发明属于药品、保健食品、食品领域,涉及一种组合物制剂及其制备方法,特别是涉及一种含维生素C钠的咀嚼片及其制备方法。
背景技术
维生素C是临床基本常用药物或营养补充剂,是抗氧化维生素当中的一种,它参与体内羟化反应,为形成骨骼、牙齿、结缔组织及非上皮组织细胞间粘物所必需,可维持牙齿、骨骼、血管的正常功能,增加对疾病的抵抗能力,为人体必需的营养元素之一,广泛应用于多种疾病预防和治疗。
片剂质量稳定、服用方便,是一种最基本、最常用的制剂形式。然而,对于儿童、老人以及吞咽困难的患者,普通片剂往往服用困难,长期服药甚至会使其产生心理上的拒药现象,咀嚼片则可弥补这种不足。咀嚼片是一类可在口腔内嚼碎后咽下的片剂,大小一般与普通片剂相同,可根据需要制成不同形状的异形片。药片经嚼碎后便于吞服,药片表面积增大,可促进药物在体内的溶解、吸收。对于难崩解的药物,制成咀嚼片可加速其崩解,提高药效。咀嚼片服用方便,即使在缺水的条件下也可以按时用药,特别适用于小儿、老人、吞咽困难或胃肠功能较差的患者,可减少药物对胃肠道的负担。因此,咀嚼片剂应用逐渐广泛起来。
由于维生素C是维持人体正常生理功能所必需的重要营养素之一,近年来维生素C咀嚼片受到了人们的青睐,然而,由于维生素C易氧化失效等问题,导致维生素C咀嚼片的使用效果及保质期受到很大影响。且维生素C咀嚼片溶解后酸性较大,对口腔、咽喉食道以及胃粘膜刺激较大,不宜长期服用,也不适合与酸性药物同时服用,在日常作为营养剂的使用或作为临床疾病的治疗或预防应用均受到一定限制。
维生素C钠是维生素C的钠盐,水溶液pH值接近中性,它的作用与维生素C相同,但由于是钠盐,所以性能更稳定,同时不再有维生素C的强酸性,可以长期与多种药物同时服用,更优于维生素C。维生素C钠属于国内外广泛使用的维生素C强化剂,已逐步替代维生素C使用。本发明直接将维生素C钠制成咀嚼片,经临床试用,制剂安全有效,且制剂简便,口感香甜适口,质量稳定。
发明内容
本发明针对现有维生素C咀嚼片溶解后酸性大、对口腔、咽喉食道以及胃粘膜刺激较大、不宜长期服用,及生产、存储过程中维生素C容易氧化失效等问题,提供一种含维生素C钠的咀嚼片及其制备方法,解决了临床上应用维生素C存在的质量不稳定、不易长期服用的问题。本发明含维生素C钠的咀嚼片,香甜适口,生物利用度高,制剂简便,质量稳定,可长期用于治疗坏血病、传染性疾病、紫癜兼有肌肉无力、瘫痪、心律失常或肾功能障碍疾病,或用于恶性肿瘤、心脑血管疾病、感染性疾病或自身免疫性疾病等的防治和辅助治疗;或作为营养补充剂长期服用。
为解决上述技术问题,本发明是通过以下技术方案实现的:
一种含维生素C钠的咀嚼片,包括以下重量份的组分:维生素C钠20-100份、淀粉200-500份、甘露醇5-20份、微晶纤维素30-100份、聚维酮K-30 5-20份、羧甲基淀粉钠10-60份、十二烷基硫酸钠5-20份、硬脂酸镁1-5份、甜味剂10-30份、薄荷香精0.1-0.5份。
以上所述的含维生素C钠的咀嚼片,最佳优选包括以下重量份的组分:维生素C钠30份、淀粉361.75份、甘露醇10份、微晶纤维素60份、聚维酮K-30 10份、羧甲基淀粉钠40份、十二烷基硫酸钠10份、硬脂酸镁3份、甜味剂20份、薄荷香精0.25份。
以上所述含维生素C钠的咀嚼片,所述甜味剂优选为阿斯巴甜、纽甜、罗汉果甜苷。
一种以上所述含维生素C钠的咀嚼片的制备方法,包括如下步骤:
S1.分别取维生素C钠、淀粉、甘露醇、微晶纤维素、聚维酮K-30、羧甲基淀粉钠、十二烷基硫酸钠、甜味剂,粉碎,过100目筛,备用;
S2.分别按配方量称取S1项下各原辅料,以等量递增法混合均匀,得混合粉;
S3.取S2项下的混合粉,一边搅拌一边加70-80%乙醇溶液制软材、制粒、过筛,干燥4小时,控制水分为2-4%,整粒,得颗粒;
S4.按配方量称取硬脂酸镁、薄荷香精,与S3项下颗粒混合均匀,压片,即得。
进一步的,步骤S3项下所述的干燥的温度为60-65℃,这样得到的颗粒硬度适中,更有利于压片;所述的过筛步骤所用的筛网优选为14-30目。
本发明的有益效果是:
1.本发明克服现有维生素C咀嚼片溶解后酸性大、对口腔、咽喉食道以及胃粘膜刺激较大、不宜长期服用,及生产、存储过程中维生素C容易氧化失效等问题,使产品稳定性更好,疗效更确切,适用于消费者或患者长期服用,无副作用。
2.本发明可用于治疗坏血病、传染性疾病、紫癜等兼有肌肉无力、瘫痪、心律失常或肾功能障碍等疾病,也可用于恶性肿瘤、心脑血管疾病、感染性疾病、自身免疫性疾病等重大疑难病症防治和辅助治疗;或作为营养补充剂长期服用。
3.本发明含维生素C钠的咀嚼片,制剂简便,颗粒流动性好,压片不粘冲,所制得的片剂外观光洁、色泽均匀,硬度适中,香甜适口,质量稳定,利地携带,方便食用,尤其适用于儿童、老年人,生物利用度高,使用更安全有效。
具体实施方式
虽然本说明书通过特别指出并清楚要求保护本发明的权利要求书作出结论,但应该相信下列说明将更好地理解本发明。
如本文所用,单词“优选”及变体是指在特定环境下能够提供特定有益效果的本发明的实施方案。然而,其它的实施方案在相同或其它的环境下也可以是优选的。此外,一个或多个优选实施方案的详述并不表示其它实施方案是无用的,并且不旨在从本发明的范畴排除其它的实施方案。
一、制剂条件筛选
1.润湿剂选择
润湿剂能使粉粒润湿,呈现粘性,以利于制备颗粒,压成片剂。本发明对比了干法压片、湿法制粒再压片,干法压片采用普通压片机效果不好,对设备要求高,故本发明采用湿法制粒再压片。试验中对比了20%麦芽糊精、30%淀粉浆、40%蔗糖糖浆、5%羟丙甲纤维素水溶液、80%乙醇做润湿剂,结果见表1。
表1润湿剂考察结果表
从表1中的试验结果可知:本发明使用80%乙醇制粒情况效果最好,故本发明润湿剂选择乙醇。为进一步优化乙醇浓度,本发明继续优化乙醇浓度,试验结果见表2。
表2乙醇浓度考察结果表
序号 | 湿润剂 | 制粒情况 | 颗粒外观 |
1 | 50%乙醇 | 成团,制粒困难 | 颗粒紧 |
2 | 60%乙醇 | 成团,制粒困难 | 颗粒紧 |
3 | 70%乙醇 | 成团,制粒不结块 | 颗粒松紧合适 |
4 | 80%乙醇 | 成团,制粒不结块 | 颗粒松紧合适 |
5 | 90%乙醇 | 不成团,制粒困难 | 颗粒松 |
从表2中的试验结果可知:本发明使用70%-80%乙醇制粒情况效果较好,浓度低太紧,浓度高太松,均影响制粒,故本发明润湿剂选择70%-80%乙醇。
2.润滑剂的选择
压片时为增加颗粒的流动性,使填充良好、片剂密度分布均匀,需加入一定的润滑剂,以解决压片时出现颗粒流动性差、易粘冲等现象。本发明试验中对比了硬脂酸镁、微粉硅胶、滑石粉、十二烷基硫酸钠、甘露醇做润滑剂时的压片情况,结果见表3。
表3润滑剂试用结果表
从表3中的试验结果可知:加入硬脂酸镁、十二烷基硫酸钠、甘露醇,流动性均较好,且压片不粘冲,压出来的片硬度合适,片面光滑美观,加入微粉硅胶,流动性好,压片时不粘冲,但压出来的片硬度低,加入滑石粉,流动性不好,压片时粘冲,压出来的片硬度大。故本发明选用硬脂酸镁、十二烷基硫酸钠、甘露醇作为润滑剂。为了调节咀嚼片的口感以及基于对生产成本的考虑,本发明试验中还对比了硬脂酸镁、十二烷基硫酸钠、甘露醇三者的比例,结果表明:硬脂酸镁、十二烷基硫酸钠、甘露醇三者的比例为3:3:1或者4:4:1其口感达到最佳。
4.矫味剂的选择
只有具有良好口感的咀嚼片才易被人们接受,因此,风味、口感非常重要,而此往往通过甜味剂、香精等矫味剂的选择来实现。本发明试验中对比如下甜味剂:蔗糖、乳糖、葡萄糖、甜菊糖、甘草酸二钠、阿斯巴甜、糖精钠、环己基氨基磺酸钠、罗汉果甜苷、纽甜、阿力甜,结果表明:上述甜味剂中阿斯巴甜、罗汉果甜苷、纽甜,在组分中比例为“甜味剂10-30份”的范围内与薄荷香精配合使用,口感风味好,甜度适中,没有不适感,其中阿斯巴甜口感最佳。故本发明选用阿斯巴甜、罗汉果甜苷、纽甜为甜味剂,并规定其加入量为10-30份。
二、含维生素C钠的咀嚼片的制备方法
实施例1
含维生素C钠的咀嚼片的制备方法,包括如下步骤:
S1.分别取维生素C钠、淀粉、甘露醇、微晶纤维素、聚维酮K-30、羧甲基淀粉钠、十二烷基硫酸钠、纽甜,粉碎,过100目筛,备用;
S2.分别按以下重量份称取S1项下各原辅料:维生素C钠30kg、淀粉361.75kg、甘露醇10kg、微晶纤维素60kg、聚维酮K-30 10kg、羧甲基淀粉钠40kg、十二烷基硫酸钠10kg、纽甜20kg,以等量递增法混合均匀,得混合粉;
S3.取S2项下的混合粉,一边搅拌一边加80%乙醇溶液制软材、过20目筛制粒,62℃干燥4小时,控制水分为2-4%,过20目筛整粒,得颗粒;
S4.按以下重量份称取:硬脂酸镁3kg、薄荷香精0.25kg,与S3项下颗粒混合均匀,压片,即得。
实施例2
含维生素C钠的咀嚼片的制备方法,包括如下步骤:
S1.分别取维生素C钠、淀粉、甘露醇、微晶纤维素、聚维酮K-30、羧甲基淀粉钠、十二烷基硫酸钠、阿斯巴甜,粉碎,过100目筛,备用;
S2.分别按以下重量份称取S1项下各原辅料:维生素C钠20kg、淀粉200kg、甘露醇5kg、微晶纤维素30kg、聚维酮K-30 5kg、羧甲基淀粉钠10kg、十二烷基硫酸钠5kg、阿斯巴甜10kg,以等量递增法混合均匀,得混合粉;
S3.取S2项下的混合粉,一边搅拌一边加70%乙醇溶液制软材、过30目筛制粒,60℃干燥4小时,控制水分为2-4%,过30目筛整粒,得颗粒;
S4.按以下重量份称取:硬脂酸镁1kg、薄荷香精0.1kg,与S3项下颗粒混合均匀,压片,即得。
实施例3
含维生素C钠的咀嚼片的制备方法,包括如下步骤:
S1.分别取维生素C钠、淀粉、甘露醇、微晶纤维素、聚维酮K-30、羧甲基淀粉钠、十二烷基硫酸钠、罗汉果甜苷,粉碎,过100目筛,备用;
S2.分别按以下重量份称取S1项下各原辅料:维生素C钠100kg、淀粉500kg、甘露醇20kg、微晶纤维素100kg、聚维酮K-30 20kg、羧甲基淀粉钠60kg、十二烷基硫酸钠20kg、罗汉果甜苷30kg,以等量递增法混合均匀,得混合粉;
S3.取S2项下的混合粉,一边搅拌一边加75%乙醇溶液制软材、过14目筛制粒,65℃干燥4小时,控制水分为2-4%,过14目筛整粒,得颗粒;
S4.按以下重量份称取:硬脂酸镁5kg、薄荷香精0.5kg,与S3项下颗粒混合均匀,压片,即得。
三、稳定性试验
将上述实施例1-3样品分别用铝塑复合膜包装好,置稳定性加速试验箱内试验:温度:40±2℃,相对湿度:75±5%,加速试验3个月,结果实施例1-3样品的外观性状、口感、硬度、脆碎度、主要成分含量等稳定性重点考察指标与0时样品测定结果比较,均无明显变化,口感风味也没有变化,说明本发明实施例1-3样品质量较为稳定,可满足贮存、运输、使用的稳定性要求。试验结果见表4。
表4维生素C钠的咀嚼片稳定性试验结果表
Claims (6)
1.一种含维生素C钠的咀嚼片,其特征在于,包括以下重量份的组分:维生素C钠20-100份、淀粉200-500份、甘露醇5-20份、微晶纤维素30-100份、聚维酮K-30 5-20份、羧甲基淀粉钠10-60份、十二烷基硫酸钠5-20份、硬脂酸镁1-5份、甜味剂10-30份、薄荷香精0.1-0.5份。
2.如权利要求1所述的含维生素C钠的咀嚼片,其特征在于,包括以下重量份的组分:维生素C钠30份、淀粉361.75份、甘露醇10份、微晶纤维素60份、聚维酮K-30 10份、羧甲基淀粉钠40份、十二烷基硫酸钠10份、硬脂酸镁3份、甜味剂20份、薄荷香精0.25份。
3.一种如权利要求1-2中任一所述含维生素C钠的咀嚼片的制备方法,其特征在于,包括如下步骤:
S1.分别取维生素C钠、淀粉、甘露醇、微晶纤维素、聚维酮K-30、羧甲基淀粉钠、十二烷基硫酸钠、甜味剂,粉碎,过100目筛,备用;
S2.分别按配方量称取S1项下各原辅料,以等量递增法混合均匀,得混合粉;
S3.取S2项下的混合粉,一边搅拌一边加70-80%乙醇溶液制软材、制粒、过筛,干燥4小时,控制水分为2-4%,整粒,得颗粒;
S4.按配方量称取硬脂酸镁、薄荷香精,与S3项下颗粒混合均匀,压片,即得。
4.如权利要求3所述含维生素C钠的咀嚼片的制备方法,其特征在于,步骤S3项下所述的干燥的温度为60-65℃。
5.如权利要求3所述含维生素C钠的咀嚼片的制备方法,其特征在于,步骤S3项下所述的过筛步骤所用的筛网为14-30目。
6.如权利要求1-3中任一所述的含维生素C钠的咀嚼片,其特征在于,所述甜味剂为阿斯巴甜、纽甜、罗汉果甜苷。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610964478.5A CN106420643B (zh) | 2016-10-28 | 2016-10-28 | 一种含维生素c钠的咀嚼片及其制备方法 |
PCT/CN2017/108406 WO2018077277A1 (zh) | 2016-10-28 | 2017-10-30 | 一种含维生素c钠的咀嚼片及其制备方法 |
US16/396,806 US20190269614A1 (en) | 2016-10-28 | 2019-04-29 | Chewable tablet containing vitamin c sodium and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610964478.5A CN106420643B (zh) | 2016-10-28 | 2016-10-28 | 一种含维生素c钠的咀嚼片及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106420643A true CN106420643A (zh) | 2017-02-22 |
CN106420643B CN106420643B (zh) | 2019-08-16 |
Family
ID=58180842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610964478.5A Active CN106420643B (zh) | 2016-10-28 | 2016-10-28 | 一种含维生素c钠的咀嚼片及其制备方法 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20190269614A1 (zh) |
CN (1) | CN106420643B (zh) |
WO (1) | WO2018077277A1 (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107049982A (zh) * | 2017-06-01 | 2017-08-18 | 防城港圣保堂制药有限公司 | 一种离子vc丸剂及其制备方法 |
CN107373479A (zh) * | 2017-06-21 | 2017-11-24 | 防城港圣保堂制药有限公司 | 一种含脐橙的离子vc组合物及其制备方法 |
WO2018077277A1 (zh) * | 2016-10-28 | 2018-05-03 | 广西圣保堂健康产业股份有限公司 | 一种含维生素c钠的咀嚼片及其制备方法 |
CN110463904A (zh) * | 2019-09-05 | 2019-11-19 | 沈阳师范大学 | 一种小麦麸皮复合营养咀嚼片及其加工方法 |
CN112121025A (zh) * | 2019-06-24 | 2020-12-25 | 翰宇药业(武汉)有限公司 | 一种单硝酸异山梨酯缓释片剂及其制备方法 |
CN112586745A (zh) * | 2020-12-30 | 2021-04-02 | 江苏艾兰得营养品有限公司 | 基于口腔速崩配方的维生素c咀嚼片及其制备工艺 |
CN112715932A (zh) * | 2020-12-25 | 2021-04-30 | 紫阳中地大硒科技有限公司 | 一种金花葵富硒咀嚼片及其制备方法 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112715878A (zh) * | 2020-12-25 | 2021-04-30 | 武汉轻工大学 | 一种黄秋葵姜黄咀嚼片及其制备方法 |
CN112716972A (zh) * | 2021-01-20 | 2021-04-30 | 北京民康百草医药科技有限公司 | 一种碳酸钙维生素d3咀嚼片及其制备方法 |
CN115176843A (zh) * | 2021-04-06 | 2022-10-14 | 大连鑫玉龙海洋生物种业科技股份有限公司 | 一种海参多肽螯合钙咀嚼片及其制作方法 |
CN113750062A (zh) * | 2021-09-05 | 2021-12-07 | 西安麦德森斯医疗科技有限公司 | 一种有机钙维生素d咀嚼片及其制备方法 |
CN114569631B (zh) * | 2022-02-08 | 2023-06-27 | 杭州民生健康药业股份有限公司 | 一种抗潮维生素矿物质片及其抗潮处理方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4372968A (en) * | 1980-09-30 | 1983-02-08 | Takeda Chemical Industries, Ltd. | Granules of sodium ascorbate and the production thereof |
CN105286021A (zh) * | 2015-11-30 | 2016-02-03 | 广州市富诺生物科技有限公司 | 一种维生素c咀嚼片及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090124639A1 (en) * | 2007-11-06 | 2009-05-14 | Emisphere Technologies Inc. | valacyclovir formulations |
CN101647805B (zh) * | 2009-09-04 | 2012-07-18 | 江苏江山制药有限公司 | 用于缓解和预防骨关节炎的氨基葡萄糖咀嚼片及制备方法 |
US8846089B2 (en) * | 2011-06-03 | 2014-09-30 | Wakunaga Pharmaceutical Co., Ltd. | Sugar-coated preparation and production method for the same |
WO2013010382A1 (zh) * | 2011-07-21 | 2013-01-24 | 山东亨利医药科技有限责任公司 | 杂环取代的嘧啶类化合物 |
CN103829118A (zh) * | 2012-11-20 | 2014-06-04 | 中国科学院兰州化学物理研究所 | 一种破壁蜂花粉咀嚼片及其制备方法 |
CN106420643B (zh) * | 2016-10-28 | 2019-08-16 | 广西圣保堂健康产业股份有限公司 | 一种含维生素c钠的咀嚼片及其制备方法 |
-
2016
- 2016-10-28 CN CN201610964478.5A patent/CN106420643B/zh active Active
-
2017
- 2017-10-30 WO PCT/CN2017/108406 patent/WO2018077277A1/zh active Application Filing
-
2019
- 2019-04-29 US US16/396,806 patent/US20190269614A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4372968A (en) * | 1980-09-30 | 1983-02-08 | Takeda Chemical Industries, Ltd. | Granules of sodium ascorbate and the production thereof |
CN105286021A (zh) * | 2015-11-30 | 2016-02-03 | 广州市富诺生物科技有限公司 | 一种维生素c咀嚼片及其制备方法 |
Non-Patent Citations (1)
Title |
---|
杨志芳: "直接压制维生素C咀嚼片", 《国外医药》 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018077277A1 (zh) * | 2016-10-28 | 2018-05-03 | 广西圣保堂健康产业股份有限公司 | 一种含维生素c钠的咀嚼片及其制备方法 |
CN107049982A (zh) * | 2017-06-01 | 2017-08-18 | 防城港圣保堂制药有限公司 | 一种离子vc丸剂及其制备方法 |
CN107373479A (zh) * | 2017-06-21 | 2017-11-24 | 防城港圣保堂制药有限公司 | 一种含脐橙的离子vc组合物及其制备方法 |
CN112121025A (zh) * | 2019-06-24 | 2020-12-25 | 翰宇药业(武汉)有限公司 | 一种单硝酸异山梨酯缓释片剂及其制备方法 |
CN112121025B (zh) * | 2019-06-24 | 2022-05-31 | 翰宇药业(武汉)有限公司 | 一种单硝酸异山梨酯缓释片剂及其制备方法 |
CN110463904A (zh) * | 2019-09-05 | 2019-11-19 | 沈阳师范大学 | 一种小麦麸皮复合营养咀嚼片及其加工方法 |
CN112715932A (zh) * | 2020-12-25 | 2021-04-30 | 紫阳中地大硒科技有限公司 | 一种金花葵富硒咀嚼片及其制备方法 |
CN112586745A (zh) * | 2020-12-30 | 2021-04-02 | 江苏艾兰得营养品有限公司 | 基于口腔速崩配方的维生素c咀嚼片及其制备工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN106420643B (zh) | 2019-08-16 |
WO2018077277A1 (zh) | 2018-05-03 |
US20190269614A1 (en) | 2019-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106420643B (zh) | 一种含维生素c钠的咀嚼片及其制备方法 | |
CN106420655A (zh) | 一种含维生素c钠的泡腾片及其制备方法 | |
US20050155519A1 (en) | Granulation process | |
WO2018077276A1 (zh) | 一种增强免疫力的组合物及其制备方法 | |
CN104173407B (zh) | 一种牛蒡低聚糖泡腾片及其制备方法 | |
CN105211687A (zh) | 一种组合物及其制备方法与用途 | |
CN101147575B (zh) | 一种排毒清肠保健食品组合物及其制备方法 | |
CN109549097A (zh) | 一种具有降糖降脂功能的保健面条 | |
CN104605224A (zh) | 一种原菠萝味维生素c钠口含片及其制备工艺 | |
WO2018077311A1 (zh) | 一种缓解视疲劳的组合物及其制备方法 | |
CN104546955A (zh) | 一种原猕猴桃味维生素c钠口含片及其制备工艺 | |
CN107303280A (zh) | 黄秋葵咀嚼片组合物及其制备方法 | |
CN103461819A (zh) | 抗肿瘤药食同膳药膳面条 | |
CN105769970A (zh) | 一种罗汉果咀嚼片及其制备方法 | |
CN105831587A (zh) | 一种控糖苦荞馒头及制备方法 | |
WO2018077275A1 (zh) | 一种保护视力的组合物及其制备方法 | |
CN107319242A (zh) | 左旋肉碱减肥泡腾片及其制备方法 | |
CN104544047B (zh) | 一种原橙味维生素c钠口含片及其制备工艺 | |
CN108201060A (zh) | 一种低gi功能面条及其制备方法 | |
CN105994740A (zh) | 铁皮石斛绿茶及其制备方法 | |
CN104544048A (zh) | 一种复合维生素c钠含片及其制备工艺 | |
CN104605223A (zh) | 一种原草莓味维生素c钠口含片及其制备工艺 | |
CN104544049A (zh) | 一种维生素c钠含片及其制备工艺 | |
CN113142367A (zh) | 一种鲨鱼软骨素乳钙压片糖果的制备方法 | |
CN107950946B (zh) | 一种即食甘草休闲食品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PP01 | Preservation of patent right |
Effective date of registration: 20210521 Granted publication date: 20190816 |
|
PP01 | Preservation of patent right |